Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP
| Report ID | 274900 |
| Drug Identification Number | 02439379 |
| Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | EPIDURAL INFILTRATION INFILTRATION EPIDURAL |
| Packaging size | 100mL |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2026-01-01 |
| Estimated end date | 2026-02-01 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2025-12-22 |
| Company comments | Due to unforeseen circumstances, our Ropivacaine Hydrochloride Injection, USP 2 mg/mL, 200 mL Bags, will be on reduced allocations starting January 1, 2026 at 50% of historical monthly demand. We are working diligently with our plant to improve the supply situation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-12-22 | French | Compare |
| v1 | 2025-12-22 | English | Compare |
Showing 1 to 2 of 2